Kraematon Investment Advisors’s Wave Life Sciences WVE Stock Holding History

Kraematon Investment Advisors’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,450	Closed	-$98.5K	–	110
2025 Q3	$98.5K	Sell	13,450 -5,910	-31%	-$47.8K	0.08%	98
2025 Q2	$126K	Buy	19,360 +475	+3%	+$3.14K	0.12%	90
2025 Q1	$153K	Sell	18,885 -1,000	-5%	-$10.9K	0.16%	88
2024 Q4	$246K	Buy	19,885 +3,885	+24%	+$51.9K	0.24%	74
2024 Q3	$131K	Sell	16,000 -3,000	-16%	-$17.9K	0.13%	83
2024 Q2	$94.8K	Sell	19,000 -3,000	-14%	-$17.1K	0.1%	84
2024 Q1	$136K	Sell	22,000 -25,000	-53%	-$125K	0.14%	87
2023 Q4	$237K	Buy	+47,000	New	+$251K	0.26%	73

Other funds holding WVE

GSK plc London $599M AUM

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Kraematon Investment Advisors's WVE Position: Q4 2025 in Review

Kraematon Investment Advisors sold out of Wave Life Sciences (WVE) in Q4 2025, closing a stake of 13,450 shares — an estimated $98.5K sold.

Kraematon Investment Advisors first reported a position in WVE in Q4 2023 and held it in 8 quarters. The position peaked at $246K in Q4 2024. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

Kraematon Investment Advisors reported no remaining Wave Life Sciences position as of Q4 2025 after selling out during the quarter.
Kraematon Investment Advisors sold 13,450 Wave Life Sciences shares in Q4 2025, an estimated $98.5K.
Kraematon Investment Advisors first reported a position in Wave Life Sciences in Q4 2023 and held it in 8 quarters.
Kraematon Investment Advisors's Wave Life Sciences position peaked at $246K in Q4 2024.
218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on Kraematon Investment Advisors's 13F filing for Q4 2025, filed 21 Jan 2026.